Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,172 GBX | -0.60% | -0.75% | +14.83% |
10:04am | ASTRAZENECA : UBS reiterates its Sell rating | ZD |
05-14 | FDA extends review of Ascendis Pharma's hormone disorder therapy | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.83% | 239B | |
+31.37% | 588B | |
-2.79% | 364B | |
+20.45% | 326B | |
+5.45% | 285B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.80% | 167B | |
+0.14% | 161B | |
+0.89% | 124B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- LumiraDx to Partner With AstraZeneca, Everton Charity Arm For Heart And Lung Screening Hub